Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 22:57:56 +0200Wed, 20 Mar 2024 12:10:00 +0100Human medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 21, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/blincytoHuman medicines European public assessment report (EPAR): Blincyto, blinatumomab, Date of authorisation: 23/11/2015, Revision: 21, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/blincytoWed, 20 Mar 2024 12:10:00 +0100Human medicineBlincyto : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/wc500198227_en.pdfBlincyto : EPAR - Public assessment reporthttps://www.ema.europa.eu/system/files/documents/assessment-report/wc500198227_en.pdfMon, 07 Dec 2015 01:00:00 +0100Human medicine